S2 Genomics

Livermore, United States

S2 Genomics is developing spatial sequencing technology solutions for processing solid tissues for single-cell applications.

$16.0M raised

Jan 2024

Series A

Top Investors

HealthTech CapitalLife Science AngelsBroadOak Capital PartnersResearch Corporation Technologies

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has S2 Genomics raised?

S2 Genomics has raised $16.0M in total funding. The most recent round was Series A. The last funding was announced in January 2024.

Who are S2 Genomics's investors?

S2 Genomics's investors include HealthTech Capital, Life Science Angels, BroadOak Capital Partners, Research Corporation Technologies.

Where is S2 Genomics headquartered?

S2 Genomics is headquartered in Livermore, United States.

What does S2 Genomics do?

S2 Genomics is developing spatial sequencing technology solutions for processing solid tissues for single-cell applications.

What stage is S2 Genomics at?

S2 Genomics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 23, 2024.

MLA

"S2 Genomics — Funding & Investors." VCBacked, January 23, 2024, https://www.vcbacked.co/company/s2-genomics. Accessed June 17, 2026.

APA

VCBacked. (2024). S2 Genomics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/s2-genomics

Wikipedia (cite web)

{{cite web |title=S2 Genomics — Funding & Investors |url=https://www.vcbacked.co/company/s2-genomics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 23, 2024.